GlassScriptPhysician profile
Tracie Shaw
NPI 1659948321
$10,031.74
in general payments reported to CMS, 2019-2025
15 companies · $1,569 in 2025
The $1,569 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $267 · 2022: $1,865 · 2023: $1,760 · 2024: $4,570 · 2025: $1,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,489 · Travel and Lodging: $2,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,488.79 |
| Travel and Lodging | $2,410.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,607.75 | 2021-2025 | Ortholoc 3di, Prostep, Citrefix |
| Empire Medical, INC | $1,215.79 | 2022 | |
| Treace Medical Concepts, INC. | $1,026.77 | 2024-2025 | |
| Medline Industries LP | $783.63 | 2024 | |
| Biotissue Holdings INC. | $436.06 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $278.54 | 2022 | |
| Organogenesis INC. | $275.00 | 2022-2025 | Puraply Wound Matrix |
| Abbvie INC. | $118.82 | 2022-2025 | |
| Smith+Nephew, INC. | $95.22 | 2021-2024 | Collagenase Santyl |
| Trimed, INC. | $73.27 | 2024 | |
| Solventum Corporation | $36.37 | 2025 | Activ.A.C. |
| Melinta Therapeutics, LLC | $24.37 | 2021 | |
| Avanos Medical | $22.29 | 2022 | |
| Bsn Medical INC | $20.04 | 2025 | |
| Bone Support INC. | $17.82 | 2024 | Cerament G, Ceramentbone Void Filler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracie Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.